share_log

Craig-Hallum Maintains Buy on Skye Bioscience, Lowers Price Target to $14

Benzinga ·  Mar 21 17:02

Craig-Hallum analyst Albert Lowe maintains Skye Bioscience (NASDAQ:SKYE) with a Buy and lowers the price target from $18 to $14.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 319

Recommended

Write a comment